News-Medical.Net

Immune Amnesia: How Measles Weaken Your Immune System

Measles can induce immune amnesia, a phenomenon that eliminates acquired immunity to other infectious diseases.
Nature

Lamprey Immune System and Variable Lymphocyte Receptors

The lamprey immune system represents an atypical model of adaptive immunity that diverges fundamentally from the well‐characterised immunoglobulin‐based system of jawed vertebrates. Instead, lampreys ...
Medscape

Pregnancy and Breastfeeding May Reprogram Breast Immunity

Pregnancy and breastfeeding leave behind long-lived CD8+ T lymphocytes that provide lasting immune protection in breast tissue, according to new research, a discovery that could reshape understanding ...
ascopubs.org

Immune landscape in lung cancer: Lymphocyte subsets as potential predictors of treatment outcomes.

Immunotherapy with and without radiotherapy following the diagnosis of bone metastasis for stage 4 non-small cell carcinoma. Efficacy and safety of nivolumab plus chemotherapy versus chemotherapy ...
ascopubs.org

Expansion and characterization of tumor-infiltrating lymphocytes from primary and metastatic immune checkpoint inhibitor-exposed renal cell carcinoma tumors.

Analysis of CA9 and PSMA expression in clear cell renal cell carcinoma (ccRCC) and the effect of prior therapies. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium.
Seeking Alpha

ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX) (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) ...
Seeking Alpha

ImmunityBio Receives FDA Expanded Access Authorization for Landmark Treatment of Lymphopenia With ANKTIVA®, the Cancer BioShield™ Platform, in Patients With Solid Tumors

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX), a leading immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Expanded Access ...